Aberrant expression of Wnt antagonist SFRP1 in pancreatic cancer

被引：0
|
作者：
BU XianminZHAO Chenghai and DAI Xianwei Department of General SurgeryShengjing HospitalChina Medical UniversityShenyangLiaoning China Department of PathophysiologySchool of Basic MedicineChina Medical UniversityShenyangLiaoning China [110004 ,110001 ]
机构：
来源：
中华医学杂志(英文版) | 2008年 / 10期
关键词：
D O I：
暂无
中图分类号：
R735.9 [胰腺肿瘤];
学科分类号：
100214 ;
摘要：
Pancreatic cancer is one of the malignant tumor with a very poor prognosis.Both genetic and epigenetic alterations are involved in the pathogenetic mechanisms of pancreatic cancer.Hypermethylation and subsequent loss of expression of some tumor suppressor
引用
收藏
页码：952 / 955
相关论文
共 50 条
  • [1] Aberrant expression of Wnt antagonist SFRP1 in pancreatic cancer
    Bu Xian-min
    Zhao Cheng-hai
    Dai Xian-wei
    [J]. CHINESE MEDICAL JOURNAL, 2008, 121 (10) : 952 - 955
  • [2] Aberrant methylation of the Wnt antagonist SFRP1 in breast cancer is associated with unfavourable prognosis
    J Veeck
    D Niederacher
    H An
    E Klopocki
    F Wiesmann
    B Betz
    O Galm
    O Camara
    M Dürst
    G Kristiansen
    C Huszka
    R Knüchel
    E Dahl
    [J]. Oncogene, 2006, 25 : 3479 - 3488
  • [3] Aberrant methylation of the Wnt antagonist SFRP1 in breast cancer is associated with unfavourable prognosis
    Veeck, J.
    Niederacher, D.
    An, H.
    Klopocki, E.
    Wiesmann, F.
    Betz, B.
    Galm, O.
    Camara, O.
    Duerst, M.
    Kristiansen, G.
    Huszka, C.
    Knuechel, R.
    Dahl, E.
    [J]. ONCOGENE, 2006, 25 (24) : 3479 - 3488
  • [4] Aberrant loss of SFRP1 expression is associated with poor prognosis in pancreatic cancer
    Jiang, Nan
    Hu, Ming-Gen
    Tang, Wen-Bo
    Yin, Zhu-Zeng
    Wang, Zi-Zheng
    Liu, Qu
    Liu, Rong
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (05): : 6064 - 6070
  • [5] Abberant methylation of the Wnt antagonist SFRP1 in breast cancer
    不详
    [J]. PATHOLOGY RESEARCH AND PRACTICE, 2005, 201 (03) : 153 - 154
  • [6] The Wnt antagonist sFRP1 in colorectal tumorigenesis
    Caldwell, GM
    Jones, C
    Gensberg, K
    Jan, S
    Hardy, RG
    Byrd, P
    Chughtai, S
    Wallis, Y
    Matthews, GM
    Morton, DG
    [J]. CANCER RESEARCH, 2004, 64 (03) : 883 - 888
  • [7] Wnt antagonist gene sFRP1 in kidney cancer progression and metastasis
    Saini, Sharanjot
    Liu, Jan
    Ahmad, Ardalan
    Shahryari, Varahram
    Majid, Shahana
    Hirata, Hiroshi
    Yamamura, Soichiro
    Kawakami, Kazumori
    Dahiya, Rajvir
    [J]. CANCER RESEARCH, 2009, 69
  • [8] WNT antagonist, SFRP1, is Hedgehog signaling target
    Katoh, Y
    Katoh, M
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2006, 17 (01) : 171 - 175
  • [9] Wnt antagonist SFRP1 functions as secreted mediator of senescence
    Elzi, David J.
    Song, Meihua
    Hakala, Kevin
    Weintraub, Susan T.
    Shiio, Yuzuru
    [J]. CANCER RESEARCH, 2011, 71
  • [10] Wnt Antagonist SFRP1 Functions as a Secreted Mediator of Senescence
    Elzi, David J.
    Song, Meihua
    Hakala, Kevin
    Weintraub, Susan T.
    Shiio, Yuzuru
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2012, 32 (21) : 4388 - 4399
12345